Sunitinib malate 是 multitargeted 酷氨酸 kinase 禁止者之一，它在诊所正在被使用。它能多于 80 种受体酷氨酸 kinase 禁止，包括表......

In this paper we discuss the rationale of applying a “sequential” targeted therapy with a specific application in clin......